Groupon Inc (GRPN) 7.07 $GRPN Final Glance: Internet

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Groupon Inc (GRPN) 7.07 $GRPN

Final Glance: Internet companies
AP - 2 hrs 24 mins ago
NEW YORK (AP) — Shares of some top Internet companies were mixed at the close of trading:
GOOGL: 549.18 (+6.26), ZNGA: 2.51 (+0.02), GRPN: 7.07 (-0.06), GOOG: 539.36 (+5.39)

Amazon Destinations to Put Expedia on Alert - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 1:53PM CDT
Yes, the rumor that Amazon.com Inc. (AMZN) is going to enter the travel booking space is absolutely correct.
AMZN: 389.80 (-1.38), EXPE: 99.47 (+1.16), GRPN: 7.07 (-0.06), PCLN: 1,212.90 (+18.64)

Defense Secretary Heads To Silicon Valley, Facebook
at Investor's Business Daily - Wed Apr 22, 1:40PM CDT
The defense secretary is heading to Silicon Valley to meet with Facebook (FB) and a top tech venture capital firm as the Pentagon looks to expand its ability to fight cyberwarfare. Ashton Carter will speak at Stanford University on Thursday for an...
FB: 84.63 (+1.01), ZNGA: 2.51 (+0.02), TWTR: 51.73 (+0.41), GRPN: 7.07 (-0.06)

Midday Glance: Internet companies
AP - Wed Apr 22, 12:39PM CDT
NEW YORK (AP) — Shares of some top internet companies are mixed at 1 p.m.:
GOOGL: 549.18 (+6.26), ZNGA: 2.51 (+0.02), GRPN: 7.07 (-0.06), GOOG: 539.36 (+5.39)

Groupon's Sale of Partial Stake in Ticket Monster Shows a Change in M&A Philosophy
at The Street - Wed Apr 22, 11:10AM CDT
Groupon's agreement to sell 46% of Ticket Monster is a sign of divestitures to come.
AMZN: 389.80 (-1.38), EBAY: 56.75 (+0.33), KKR: 23.37 (+0.21), GRPN: 7.07 (-0.06)

Early Glance: Internet companies
AP - Wed Apr 22, 9:25AM CDT
NEW YORK (AP) — Shares of some top internet companies are mixed at 10 a.m.:
GOOGL: 549.18 (+6.26), ZNGA: 2.51 (+0.02), GRPN: 7.07 (-0.06), GOOG: 539.36 (+5.39)

Yahoo 1Q 2015: Core Business Bleeding as Costs Rise - Analyst Blog
Sejuti Banerjea - Zacks Investment Research - Wed Apr 22, 7:20AM CDT
Yahoo's (YHOO) first-quarter adjusted earnings of a little over 7 cents matched the Zacks Consensus Estimate of 7 cents.
YHOO: 43.97 (-0.52), ABTL: 16.20 (+0.98), FB: 84.63 (+1.01), GRPN: 7.07 (-0.06), MSFT: 42.98 (+0.35)

Jobs Are Everywhere, But Making A Living Is Still Tough
MyTradingIncome - Seeking Alpha - Tue Apr 21, 4:48PM CDT
These days, finding a job isn't nearly as hard as it used to be. According to the Bureau of Labor Statistics, the unemployment level is now at 5.5%, well below the peak level of 10.0% recorded in October of 2009. An unemployment rate of 5.5 percent...
AMZN: 389.80 (-1.38), COH: 41.59 (+0.10), ANGI: 6.46 (+0.31), TGT: 81.34 (+0.09), TIF: 85.10 (+0.95), GRPN: 7.07 (-0.06)

Under Armour and Teva are big market movers
AP - Tue Apr 21, 3:31PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
BAM: 55.54 (+0.09), HAS: 71.73 (-1.82), HOG: 56.23 (+0.51), RTN: 109.65 (+0.82), HAL: 47.11 (+0.06), RMBS: 14.40 (+0.22), CZR: 9.68 (-0.24), FARO: 44.64 (-0.93), UA: 82.27 (-1.25), RCL: 73.23 (-0.68), LRE: 8.43 (+0.08), TEVA: 63.01 (-1.15), GRPN: 7.07 (-0.06), SANM: 21.09 (+0.40)

Trade-Ideas: Groupon (GRPN) Is Today's "Roof Leaker" Stock
at The Street - Tue Apr 21, 12:58PM CDT
Trade-Ideas LLC identified Groupon (GRPN) as a "roof leaker" (crossing below the 200-day simple moving average on higher than normal relative volume) candidate
GRPN: 7.07 (-0.06)

Lam Research (LRCX) Q3 Earnings Beat on Higher Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 21, 9:27AM CDT
Lam Research Corporation (LRCX) reported third-quarter fiscal 2015 non-GAAP earnings of $1.40 per share, which beat the Zacks Consensus Estimate by 10 cents.
ABTL: 16.20 (+0.98), PETS: 17.11 (+0.13), LRCX: 78.36 (+0.52), GRPN: 7.07 (-0.06)

Could Amazon Do To Groceries What It Did To Books?
Karen Webster - at Seeking Alpha - Tue Apr 21, 4:33AM CDT
Editor's note: Originally published on April 6, 2015 Amazon’s (NASDAQ: AMZN ) launch of Dash might be the best look we’ve had so far into how Amazon thinks about omnichannel. And, its plans to totally disrupt the grocery category, for...
WFM: 48.60 (-0.37), AMZN: 389.80 (-1.38), KR: 70.39 (-1.44), EBAY: 56.75 (+0.33), ETSY: 25.12 (-0.63), PG: 83.09 (+0.01), GRPN: 7.07 (-0.06), BABA: 82.05 (-0.37)

Groupon to Offload a Stake in E-Commerce Business of Ticket Monster
at The Street - Mon Apr 20, 5:32PM CDT
Groupon has sealed a deal to offload a stake in Ticket Monster to a consortium of private-equity firms for $360 million.
GRPN: 7.07 (-0.06)

Groupon (GRPN) Stock Gains Today on Sale of Ticket Monster Stake
at The Street - Mon Apr 20, 4:11PM CDT
Groupon (GRPN) shares are gaining after announcing it will sell a stake of Ticket Monster for $360 million.
GRPN: 7.07 (-0.06)

Earnings Time Bomb For 9 Stocks: A 'Weighty Matter'
Abe Garver - Seeking Alpha - Mon Apr 20, 9:14AM CDT
DIM pricing may send shares of certain e-commerce companies into a free-fall The convenience of online shopping with in-home delivery, has resulted in an increase in the number of lighter weight packages in bulkier boxes being shipping to homes...
W: 32.32 (-0.28), PRTS: 2.07 (-0.02), PETS: 17.11 (+0.13), NTRI: 19.80 (+0.14), NILE: 27.19 (-0.62), OSTK: 24.11 (-0.58), GRPN: 7.07 (-0.06), FLWS: 10.96 (+0.14), ZU: 13.56 (+0.12)

Groupon sells control of Ticket Monster for $360M, announces buyback
Seeking Alpha - at Seeking Alpha - Mon Apr 20, 7:59AM CDT

GRPN: 7.07 (-0.06)

Groupon Agrees to Sell Ticket Monster Stake to KKR, Anchor; Announces New $300 Million Share Repurchase Program
Business Wire - Mon Apr 20, 7:31AM CDT
Groupon announced today it has entered an agreement to sell a controlling 46 percent fully diluted stake in Ticket Monster (TMON), its South Korean e-commerce business, for $360 million, to a partnership formed by leading global investment firm KKR and Hong Kong-based Anchor Equity Partners. The investments value Ticket Monster at $782 million on a fully diluted basis, assuming a full vesting of management's 13 percent stake. At closing, Groupon will retain a fully diluted 41 percent stake in TMON.
GRPN: 7.07 (-0.06)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 170

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 358

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 336

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 364

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 86

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 372

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 64

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading

Top 5 Most Recently Viewed Articles

Analyzing Trump's Executive Orders and Their Economic Impact

Updated Category News Views 806

Executive Orders: A Shift in Economic Paradigms President Trump has taken significant steps by issuing a number of executive orders that have raised eyebrows among economists and market analysts alike. According to market expert Louis Navellier, this approach can be characterized as 'shock and awe'. It reflects a bold strategy that could reshape various aspects of the...

Continue Reading
B2PRIME Expands Institutional Reach with Stuart Brock's Addition

Updated Category News Views 173

B2PRIME Welcomes Stuart Brock as Institutional Business Development Manager B2PRIME Group, a leading financial services provider for institutional and professional clients, recently announced the appointment of Stuart Brock as its Institutional Business Development Manager. With over 15 years of experience in electronic trading and institutional sales, Stuart is poised to...

Continue Reading
United Parks & Resorts Inc. Shares Q1 2025 Financial Insights

Updated Category News Views 374

Financial Overview of United Parks & Resorts Inc. United Parks & Resorts Inc. (NYSE: PRKS), a prominent player in the theme park and entertainment sector, has recently shared its financial results for the first quarter of 2025. This report delves into the key metrics and operational insights that define the company’s performance in this period. Attendance and Revenue...

Continue Reading
Seongnam Pavilion Sets New Benchmark at CES 2025 with 41 Companies

Updated Category News Views 178

Seongnam Pavilion Makes Waves at CES 2025 At the latest CES 2025, Seongnam City showcased an impressive turnout at the world's leading consumer electronics exhibition. This year, Seongnam participated with a remarkable delegation of 41 companies, marking the largest participation ever. Focused on enhancing their global footprint, these small and medium-sized enterprises...

Continue Reading
Gaucho Holdings Seizes Opportunities Amid Argentina's Economic Revival

Updated Category News Views 179

Gaucho Holdings and the New Economic Landscape in Argentina Recently, Argentina has entered a new chapter of economic transformation. A shift in leadership, with Javier Milei becoming president, has sparked hopes for fiscal discipline, growth, and development. As the country embraces pro-market reforms, Gaucho Group Holdings, Inc. (NASDAQ: VINO) positions itself to...

Continue Reading